Point72 (DIFC)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-66,564
Closed -$411K 946
2024
Q2
$411K Buy
66,564
+57,030
+598% +$352K 0.01% 298
2024
Q1
$48.4K Buy
+9,534
New +$48.4K ﹤0.01% 673